leuprolide has been researched along with Acromegaly* in 1 studies
1 other study(ies) available for leuprolide and Acromegaly
| Article | Year |
|---|---|
Complete response to the combination therapy with androgen blockade and somatostatin analogue in a patient with advanced prostate cancer: magnetic resonance imaging with 1H-spectroscopy.
A 74-yr-old man with prostatic adenocarcinoma underwent magnetic resonance 1H-spectroscopic imaging (1H-MRSI) of the prostate. Based on the results, he was treated with combination therapy using complete androgen blockade (leuprorelin acetate 3.75 mg every 4 wk plus bicalutamide 50 mg daily) and a somatostatin analogue (lanreotide acetate 60 mg every 4 wk). Serum prostate-specific antigen and chromogranin A levels steadily decreased over a 12-mo follow-up period, at which time the patient is alive without disease progression and with a complete objective and symptomatic response. Topics: Acromegaly; Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents; Diagnosis, Differential; Drug Therapy, Combination; Follow-Up Studies; Humans; Leuprolide; Magnetic Resonance Spectroscopy; Male; Peptides, Cyclic; Prostatic Neoplasms; Severity of Illness Index; Somatostatin; Time Factors | 2008 |